Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

The Biggest Patent Rulings Of 2025: A Midyear Report No Photo Available

Ryan Davis

A ruling by the full Federal Circuit invited greater scrutiny of patent damages testimony, and the U.S. Patent and Trademark Office's ... (more story)

Healthcare Deals That Shaped 2025: Midyear Highlights No Photo Available

Yeji Jesse Lee

As 2025 hits its midyear point, Law360 Healthcare Authority asked attorneys for their top choices for influential deals that have help... (more story)

Texas Goes Big On New Healthcare Laws No Photo Available

Mark Payne

It may be mid-summer, but Texas lawmakers are sending doctors and lawyers back to school for a course on what constitutes a "medical e... (more story)